Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction.
- Resource Type
- Article
- Source
- Human Vaccines & Immunotherapeutics; 2020, Vol. 16 Issue 10, p2559-2564, 6p
- Subject
- Language
- ISSN
- 21645515